Baclofen for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 10 registered trials.

Why this status

  1. 1 Feb 2016: Trial started, NCT03293017
  2. 30 Mar 2016: Trial registered, NCT02723383
  3. 27 Jun 2016: Trial started, NCT02723383
  4. 26 Sep 2017: Trial registered, NCT03293017

The trials

NCT00877734: Efficacy and Tolerability of Baclofen for Alcohol Dependence

State
Completed
Phase
Phase 2 and Phase 3
People
80 taking part
Started
Apr 2005
Primary completion
May 2007
Arms
1
Results
None posted
  1. 8 Apr 2009: Trial registered

NCT01002105: Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients

State
Completed
Phase
Phase 4
People
75 taking part
Started
Jan 2010
Primary completion
May 2012
Arms
Baclofen
Results
Posted on the registry
  1. 27 Oct 2009: Trial registered
  2. 27 Jan 2017: Trial results posted

NCT01008280: Baclofen to Reduce Alcohol Use in Veterans With HCV

State
Completed
Phase
Phase 4
People
180 taking part
Started
Oct 2010
Primary completion
Mar 2014
Arms
Baclofen
Results
Posted on the registry
  1. 5 Nov 2009: Trial registered
  2. 9 Jun 2015: Trial results posted

NCT01266655: Baclofen for the Treatment of Alcohol Dependence

State
Completed
Phase
Phase 2 and Phase 3
People
56 taking part
Started
Feb 2011
Primary completion
May 2014
Arms
Baclofen
Results
None posted
  1. 24 Dec 2010: Trial registered

NCT01604330: Baclofen for the Treatment of Alcohol Drinkers

State
Completed
Phase
Phase 2 and Phase 3
People
323 taking part
Started
29 May 2012
Primary completion
Sep 2014
Arms
Baclofen
Results
None posted
  1. 23 May 2012: Trial registered
  2. 29 May 2012: Trial started

NCT01711125: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease

State
Completed
Phase
Phase 3
People
104 taking part
Started
Mar 2013
Primary completion
Jun 2017
Arms
Arm 1, Arm 2
Results
None posted
  1. 22 Oct 2012: Trial registered

NCT01738282: Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients

State
Completed
Phase
Phase 3
People
316 planned
Started
Dec 2012
Primary completion
Jul 2014
Arms
Baclofen
Results
None posted
  1. 30 Nov 2012: Trial registered

NCT01751386: Baclofen for Treating Anxiety and Alcoholism

State
Completed
Phase
Phase 2
People
39 taking part
Started
3 Dec 2012
Primary completion
17 Aug 2016
Arms
Baclofen
Results
Posted on the registry
  1. 18 Dec 2012: Trial registered
  2. 17 Aug 2016: Trial completed
  3. 16 Aug 2017: Trial results posted

NCT02723383: Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU

State
Completed
Phase
Phase 3
People
314 taking part
Started
27 Jun 2016
Primary completion
14 Aug 2019
Arms
BACLOFEN
Results
None posted
  1. 30 Mar 2016: Trial registered
  2. 27 Jun 2016: Trial started
  3. 14 Aug 2019: Trial completed

NCT03293017: Baclofen in Managing Acute Alcohol Withdrawal

State
State not given
Phase
Phase 4
People
90 planned
Started
1 Feb 2016
Primary completion
1 Feb 2022
Arms
Baclofen 30 mg/day, Baclofen 60 mg/day
Results
None posted
  1. 1 Feb 2016: Trial started
  2. 26 Sep 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Baclofen 30mg, Baclofen 30mg/day, Baclofen 60mg, Baclofen 75mg/day, Fleqsuvy, Gablofen, Kemstro, Lioresal, Lyvispah, Ozobax.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.